Back to search

Democritus University of Thrace (DUTH)

Διερεύνηση της κλινικής σημασίας μοριακών δεικτών που συμμετέχουν σε κομβικά μονοπάτια της καρκινογένεσης του μη-μικροκυτταρικoύ καρκίνου του πνεύμονα

Abstract

dc:description

Prognosis of patients with non-small cell lung cancer (NSCLC) remains dismal, with the exception of patients with early operable disease that exhibits the best rates of overall survival. In this subgroup of patients, there is urgent need for novel biomarkers with prognostic and/or predictive value. The main role of DNA repair is to correct the damages of DNA that are implicated in the process of carcinogenesis. Key molecule in this system is H2AX, and more specifically its phosphorylated type. The aim of our study was to examine the prognostic role of γ-Η2ΑΧ in patients with early operable NSCLC. We studied the immunohistochemical expression of γ-Η2ΑΧ as well as the expression levels of BRCA1 with RT-PCR, a molecule that is also implicated in the DNA repair system. We also studied the expression of p53, a classical key molecule in the regulation of apoptosis in combination with analysis of caspase 3 levels. Furthermore, we examined the genomic instability of our samples by analyzing the ploidy status with flow cytometry, Ki67 labeling index and EGFR mutations in the same cohort of 96 patients with early operable NSCLC. Our results showed that low expression levels of γ-Η2ΑΧ represent an independent factor of better overall survival in patients with early operable NSCLC. Patients with high expression levels of γ-Η2ΑΧ had a siginificantly worse overall survival (23.2 months vs 35.3 months of patients with low expression of γ-Η2ΑΧ, p=0.009). High expression levels of γ-Η2ΑΧ were significantly correlated with Τ3 tumors, advanced stage (ΙΙΙ/IV), lymphatic infiltration, aneuploidy and high expression levels of BRCA1. We also analyzed the combination of γ-Η2ΑΧ/p53 in order to define subgroups with different survival rates. The subgroup of patients with γ-Η2ΑΧ low/p53 low expression levels was associated with best survival rates as compared to the other expression profiles. Regarding BRCA1 expression analysis, our results were in keeping with the literature, showing that low BRCA1 expression levels were associated with a marginally siginificant better survival (p=0.08). An interesting finding of our results was that in the combined BRCA1/p53 analysis, BRCA1 expression was the determining factor of survival and not p53. In this context, patients with low expression of BRCA1 had a similar survival irrespective of p53 expression. We also found that BRCA1 and γ-Η2ΑΧ were significantly associated. No correlation between BRCA1 levels and EGFR mutations was detected. The use of multivariate cox proportional hazards regression analysis showed that independent factors for worse overall survival were: a) squamous carcinomas, b) N2 tumors, c) low grade tumors, d) tumors with high expression of p53 and e) tumors with high expression of γ-Η2ΑΧ. Regarding the progression free survival, patients with low expression of γ-Η2ΑΧ had an increased PFS as compared to patients with high γ-Η2ΑΧ (p=0,024). Similarly, patients with low expression of BRCA1 had also an increased PFS in comparison to patients with high expression of BRCA1 (p=0.021). Finally we analyzed our data with artificial neural networks (ANNs). ANNs outweighed logistic regression analysis in terms of accuracy. ANNs had a prediction success rate of about 88%. Although the success rate of correct prediction was not 100%, this study shows that the rate can be improved step by step when parameters and novel molecular parameters involved in lung cancer are added and considered together.

Degree

thesis:*
Grantor dc:publisher
Democritus University of Thrace (DUTH)
Year dc:date
2013

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Matthaios, Dimitrios
  • Ματθαίος, Δημήτριος

Subjects

dc:subject × 23

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/39097

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Matthaios, Dimitrios; Ματθαίος, Δημήτριος. Διερεύνηση της κλινικής σημασίας μοριακών δεικτών που συμμετέχουν σε κομβικά μονοπάτια της καρκινογένεσης του μη-μικροκυτταρικoύ καρκίνου του πνεύμονα. Democritus University of Thrace (DUTH), 2013. http://hdl.handle.net/10442/hedi/39097